RT Book, Section
A1 Juncos, Jorge L.
A2 Watts, Ray L.
A2 Standaert, David G.
A2 Obeso, Jose A.
SR Print(0)
ID 55802505
T1 Chapter 39. Tourette Syndrome and Related Disorders
T2 Movement Disorders, 3e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-161312-5
LK neurology.mhmedical.com/content.aspx?aid=55802505
RD 2024/04/19
AB In  his  now  famous  1885  publication,  George  Gilles  de  la  Tourette  described  the  illness  that  now  bears  his  name.  He  reported  nine  patients  with  motor  and  vocal  tics,  some  of  whom  had  echophenomena  and  coprolalia  (vide  infra).1  Up  to  the  past  few  decades  Tourette  syndrome  (TS)  was  viewed  as  a  rare  and  disabling  condition  with  bizarre  symptoms  and  unknown  etiology.  Although  our  understanding  of  the  disorder  is  still  incomplete,  it  has  improved  considerably  as  a  result  of  the  body  of  clinical,  neuroscience,  imaging,  and  genetic  data  that  has  accumulated  since.  This  new  knowledge  has  led  to  a  paradigm  shift  in  the  thinking  about  TS,  and  to  more  informed  and  effective  approaches  to  the  illness.  This  research  and  resulting  evolution  in  our  clinical  approaches  to  patients  with  TS  are  the  foci  of  this  chapter.